# POLR3A-related syndrome complicated with cerebral abscesses: a case report and literature review

**Authors:** Mengyao Zhou, Lingli Hou, Huijuan Fan, Yuanfang Duan, Xinye Xie, Haohao Wu, Hanmin Wang, Wei Zhang, Kang Du

PMC · DOI: 10.3389/fgene.2026.1668022 · Frontiers in Genetics · 2026-02-05

## TL;DR

A case of POLR3A-related syndrome in a child with cerebral abscesses is reported, expanding the known complications of this genetic disorder.

## Contribution

The novel finding is the association of cerebral abscesses with POLR3A-related syndrome, a previously unreported complication.

## Key findings

- A homozygous c.1771-6C>G variant in POLR3A was identified in a patient with cerebral abscesses.
- Cerebral atrophy and white matter hypomyelination were common neuroimaging findings in POLR3A-related syndrome.
- c.1909 + 22G>A was the most prevalent variant in POLR3A-related syndrome cases reviewed.

## Abstract

POLR3A gene-related syndrome is a complex genetic disorder with diverse clinical manifestations. Understanding its characteristics is crucial for diagnosis and management. Previous studies have reported various aspects of this syndrome, yet a comprehensive analysis of different Variant sites and their associated phenotypes remains necessary.

This study presents a case of POLR3A-related syndrome in a pediatric patient. Symptom onset occurred after 2 years of age, initially presenting with gait disturbance. As the disease progressed, gait instability worsened progressively and was accompanied by dysarthria, intellectual developmental impairment, and tremor. Subsequent neuroimaging revealed multiple intracerebral infectious lesions with abscess formation. Whole-genome sequencing identified a homozygous c.1771-6C>G variant in the POLR3A gene. This variant has been previously reported as pathogenic at this locus; however, the complication of multiple intracerebral infections and abscess formation represents a previously unreported manifestation. It is noteworthy that the parents of the proband were consanguineous (first-degree relatives).

A review of 60 unrelated probands with POLR3A-related syndrome was conducted based on previously published cases. The analysis revealed no significant sex difference in disease occurrence. The median age of onset was approximately 8 years, with common initial symptoms including gait disturbance and cognitive developmental impairment. Neuroimaging findings indicated cerebral atrophy in 31 cases (66.0%) and white matter hypomyelination in 17 cases (34.7%). Among the reported genetic variants, c.1909 + 22G>A was the most prevalent, identified in 19 families (17.8%), followed by c.1771-6C>G in 9 families (6.4%). Furthermore, patients with different variant sites displayed heterogeneity in initial symptoms, clinical presentations, and imaging characteristics. This comprehensive review enhances the understanding of the phenotypic and genotypic spectrum of POLR3A-related syndrome.

## Linked entities

- **Genes:** POLR3A (RNA polymerase III subunit A) [NCBI Gene 11128]

## Full-text entities

- **Genes:** TRE-TTC3-1 (tRNA-Glu (anticodon TTC) 3-1) [NCBI Gene 7193] {aka TRE, TRNAE1, TRNE}, CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}, SPAST (spastin) [NCBI Gene 6683] {aka ADPSP, FSP2, SPG4}, POLR3C (RNA polymerase III subunit C) [NCBI Gene 10623] {aka C82, RPC3, RPC62}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, POLR3A (RNA polymerase III subunit A) [NCBI Gene 11128] {aka ADDH, C160, HLD7, RPC1, RPC155, WDRTS}, CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, POLR3K (RNA polymerase III subunit K) [NCBI Gene 51728] {aka C11, C11-RNP3, HLD21, My010, RPC10, RPC11}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, SMG1 (SMG1 nonsense mediated mRNA decay associated PI3K related kinase) [NCBI Gene 23049] {aka 61E3.4, ATX, LIP}, POLR3B (RNA polymerase III subunit B) [NCBI Gene 55703] {aka C128, CMT1I, HLD8, INMAP, RPC2}
- **Diseases:** pes cavus (MESH:D000070589), facial dysmorphism (MESH:C565579), dyskinesia (MESH:D004409), 4H syndrome (MESH:C567313), gait impairment (MESH:D020234), autoimmune antibody (MESH:D001327), speech disorders (MESH:D013064), Gait disturbances (MESH:D020233), leukodystrophy (MESH:D007966), white matter abnormalities (MESH:D056784), dental developmental abnormalities (MESH:D000094602), T2-hyperintense (MESH:C535434), dental abnormalities (MESH:D014071), thinning of the corpus callosum (MESH:C538335), peripheral neuropathy (MESH:D010523), intellectual developmental impairment (MESH:C565406), nystagmus (MESH:D009759), ventricular enlargement (MESH:D006332), cerebellar dysarthria (MESH:D004401), hepatitis (MESH:D056486), brain abscess (MESH:D001922), spinal cord atrophy (MESH:D013118), abnormal tooth development (MESH:D002658), gait instability (MESH:D043171), spastic paraplegia (MESH:D010264), SCP hyperintensity (MESH:D002526), fever (MESH:D005334), hereditary spastic paraplegia (MESH:D015419), convulsions (MESH:D012640), SA (MESH:D013615), genetic (MESH:D030342), HIV (MESH:D015658), neurologic dysfunction (MESH:D009461), central nervous system infection (MESH:D002494), hypodontia (MESH:D000848), hypogonadism (MESH:D007006), intracerebral infectious lesions (MESH:D003141), motor dysfunction (MESH:D000068079), dysmyelination of the cranial nerves (MESH:D003389), Hereditary ataxia (MESH:D013132), gonadal developmental abnormalities (MESH:D006058), spastic ataxia (MESH:C564815), corpus callosum atrophy (MESH:D061085), spastic tetraplegia (MESH:D011782), Cognitive impairment (MESH:D003072), abnormalities (MESH:D000014), syphilis (MESH:D013587), Swallowing difficulties (MESH:D003680), dystonia (MESH:D004421), dental anomalies (OMIM:614188), epilepsy (MESH:D004827), abscess (MESH:D000038), muscle atrophy (MESH:D009133), limb spasm (MESH:D013035), sensory nerve impairment (MESH:D005155), autosomal recessive or sporadic cerebellar ataxia (MESH:D002524), headache (MESH:D006261), neurodegenerative disease (MESH:D019636), spasticity (MESH:D009128), hypomyelinating leukodystrophy (MESH:C536319)
- **Chemicals:** glutamate (MESH:D018698), piperacillin-tazobactam sodium (-), homocysteine (MESH:D006710), amino acids (MESH:D000596), aspartate (MESH:D001224)
- **Species:** HF [taxon 2008765], Legionella sp. H (species) [taxon 66966], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** 1980 G>C, 3839dupT, 3295C>T, 2381A>C, 930G>C, c.2015G>A, 2549A>G, c.2003 + 18G>A, 2044C>T, 2325C>G, 2668G>T, 2324A>T, 2005C>T, c.1909 + 22 G>A, 1745G>A, 3655G>T, 22 G>A, 1795C>A, 4037G>A, c.3336G>A, 3568C>T, 2830G>T, c.1674C>G, 4044C>G, 1114G>A, c.2171G>A, 2A>G, 3858C>A, 328A>G, c.2710 G>A, 4006C>T, 1682G>A, 592G>T, 2554A>G, c.1911 + 18C>T, 1907C>A, 2671C>T, 346A>G, 1757C>T, 1781T>G, 7C>G, c.2423G>A, 128913A>C, 2693delT, 928T>A, 3205C>T, -35C>G, 1G>A, 6 C>G, c.1378_1380del, 11T>C, 418C>T, 3226G>A, 791C>T, 3745A>C, 3013C>T, c.1771-6 C>G, 1993dupT, 1787C>T

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916066/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12916066/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916066/full.md

---
Source: https://tomesphere.com/paper/PMC12916066